These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 14116132)
1. RELAXIN IN THE TREATMENT OF LOCALISED SCLERODERMA. WELLS RS Trans St Johns Hosp Dermatol Soc; 1963; 49():149-51. PubMed ID: 14116132 [No Abstract] [Full Text] [Related]
2. Failure of relaxin inthe treatment of scleroderma. JEFFERIS JE; DIXON AS Ann Rheum Dis; 1962 Sep; 21(3):295-7. PubMed ID: 14028943 [No Abstract] [Full Text] [Related]
3. Relaxin (releasin) therapy in diffuse progressive scleroderma; a preliminary report. EVANS JA AMA Arch Derm; 1959 Feb; 79(2):150-8. PubMed ID: 13616712 [No Abstract] [Full Text] [Related]
4. Use of relaxin in the treatment of scleroderma. CASTEN GG; BOUCEK RJ J Am Med Assoc; 1958 Jan; 166(4):319-24. PubMed ID: 13491339 [No Abstract] [Full Text] [Related]
5. THE USE OF RELAXIN IN PROGRESSIVE SYSTEMIC SCLEROSIS AND OTHER CONNECTIVE TISSUE DISEASES. A CLINICAL STUDY. RIVELIS AL; TRAEGER C; ROGOFF B Arch Interam Rheumatol; 1965; 8():19-31. PubMed ID: 14316749 [No Abstract] [Full Text] [Related]
6. Relaxin: its effects in a case of acrosclerosis. ISMAY G Br J Dermatol; 1958 May; 70(5):171-5. PubMed ID: 13536246 [No Abstract] [Full Text] [Related]
8. Localized and systemic scleroderma. Hawk A; English JC Semin Cutan Med Surg; 2001 Mar; 20(1):27-37. PubMed ID: 11308134 [TBL] [Abstract][Full Text] [Related]
9. Localised scleroderma. (A brief review with study of 3 cases). INGLE VN; KHETERPAL SK Indian J Child Health; 1963 Mar; 12():176-81. PubMed ID: 13956511 [No Abstract] [Full Text] [Related]
10. Pulmonary fibrosis in scleroderma: report of a case with pulmonary function studies to evaluate corticosteroid and relaxin therapy. TRANQUADA RE; SIMMONS DH; MILLER JH Arch Intern Med; 1960 Apr; 105():607-12. PubMed ID: 13839183 [No Abstract] [Full Text] [Related]
11. Widened periodontal ligament in systemic and localised scleroderma. Chawla YC; Bhatia B; Bhatia KK J Indian Dent Assoc; 1985 Jul; 57(7):263-5. PubMed ID: 3869150 [No Abstract] [Full Text] [Related]
12. Safety and pharmacokinetics of recombinant human relaxin in systemic sclerosis. Seibold JR; Clements PJ; Furst DE; Mayes MD; McCloskey DA; Moreland LW; White B; Wigley FM; Rocco S; Erikson M; Hannigan JF; Sanders ME; Amento EP J Rheumatol; 1998 Feb; 25(2):302-7. PubMed ID: 9489823 [TBL] [Abstract][Full Text] [Related]
13. Prognosis and management of scleroderma and scleroderma-like disorders in children. Black CM Clin Exp Rheumatol; 1994; 12 Suppl 10():S75-81. PubMed ID: 7955633 [TBL] [Abstract][Full Text] [Related]
14. [Pathogenesis and therapy of angioneuropathy]. RATSCHOW M Z Kreislaufforsch; 1950 May; 39(9-10):296-306. PubMed ID: 15431856 [No Abstract] [Full Text] [Related]
16. [Prognosis and treatment of scleroderma]. Crickx B; Belaich S Ann Med Interne (Paris); 1984; 135(8):624-9. PubMed ID: 6529058 [TBL] [Abstract][Full Text] [Related]
17. [Relaxin in the treatment of sclerodermas. Preliminary note]. KAMINSKY A; KAMINSKY CA; DE KAMINSKY AR Dia Med; 1960 Jun; 32():1200-4. PubMed ID: 13751045 [No Abstract] [Full Text] [Related]
18. SF-36 Scales in the Relaxin study. Khanna D; Park GS; Seibold J Rheumatology (Oxford); 2007 Apr; 46(4):724. PubMed ID: 17289790 [No Abstract] [Full Text] [Related]
19. [Electrophoresis and colloid tests in generalized scleroderma and various forms of localized scleroderma]. PENDE G Arch Maragliano Patol Clin; 1951; 6(6):1149-62. PubMed ID: 14924836 [No Abstract] [Full Text] [Related]